Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation

• Jessica Wagoner,

  Affiliation Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Chihiro Morishima,

  Affiliation Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Tyler N. Graf,

  Affiliation Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina, United States of America

  ⨯
• Nicholas H. Oberlies,

  Affiliation Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina, United States of America

  ⨯
• Elodie Teissier,

  Affiliations Institut de Biologie et Chimie des Protéines, UMR CNRS 5086, Université Lyon 1, IFR128 Lyon Biosciences Gerland, Lyon, France, CNRS-Universite Claude Bernard, Lyon, France

  ⨯
• Eve-Isabelle Pécheur,

  Affiliations Institut de Biologie et Chimie des Protéines, UMR CNRS 5086, Université Lyon 1, IFR128 Lyon Biosciences Gerland, Lyon, France, CNRS-Universite Claude Bernard, Lyon, France

  ⨯
• John E. Tavis,

  Affiliation Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Stephen J. Polyak

  * E-mail: polyak@uw.edu

  Affiliations Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America, Department of Microbiology, University of Washington, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America

  ⨯